Risk factors for and prognosis of carboplatin-related hypersensitivity in patients with epithelial ovarian cancer.

Woo Yeon HwangMinjung LeeDong Hoon SuhKidong KimJae Hong NoYong Beom KimJu-Hyun Kim

Published in: Archives of gynecology and obstetrics (2022)

In EOC patients, prior use of carboplatin was an independent risk factor for carboplatin-related HRs; HRs to carboplatin did not influence the overall survival. Clinicians should not underestimate the possibility risk of carboplatin HSRs when re-administrating carboplatin in EOC patients.

Keyphrases

phase ii study
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
phase iii
peritoneal dialysis
squamous cell carcinoma
radiation therapy
patient reported outcomes
open label
study protocol
locally advanced
rectal cancer